Cargando…
CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
Huntington disease (HD) is a fatal dominantly inherited neurodegenerative disorder caused by CAG repeat expansion (>36 repeats) within the first exon of the huntingtin gene. Although mutant huntingtin (mHTT) is ubiquitously expressed, the brain shows robust and early degeneration. Current RNA int...
Autores principales: | Monteys, Alex Mas, Ebanks, Shauna A., Keiser, Megan S., Davidson, Beverly L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363210/ https://www.ncbi.nlm.nih.gov/pubmed/28129107 http://dx.doi.org/10.1016/j.ymthe.2016.11.010 |
Ejemplares similares
-
Haplotyping SNPs for allele-specific gene editing of the expanded huntingtin allele using long-read sequencing
por: Fang, Li, et al.
Publicado: (2022) -
Haplotyping SNPs for allele-specific gene editing of the expanded huntingtin allele using long-read sequencing
por: Fang, Li, et al.
Publicado: (2023) -
RNAi prevents and reverses phenotypes induced by mutant human ataxin‐1
por: Keiser, Megan S., et al.
Publicado: (2016) -
CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease
por: Kolli, Nivya, et al.
Publicado: (2017) -
Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)